# Diageo PLC (DGE.L) - Investment Thesis v2.0

**Date:** 2026-02-03
**Analyst:** Fundamental Analyst Agent
**Status:** WATCHLIST - Lower price target required
**Framework Version:** v2.0 (business-analysis + projection + multi-method valuation)

---

## 1. Executive Summary

Diageo is the world's largest spirits company with iconic brands (Johnnie Walker, Guinness, Smirnoff, Tanqueray) trading at 1690 GBp after a 29% decline from 52-week highs. The market is pricing in: (1) near-zero organic growth, (2) high leverage (3.4x EBITDA), and (3) China/US consumer weakness.

**Why cheap:** Organic growth stalled (FY26 guidance: flat to slightly down), leverage elevated, US/China headwinds. P/E 22x trailing but ~13x forward.

**My counter-thesis (WEAK):** Multi-method valuation shows Diageo is NOT cheap at 1690 GBp. DCF, EV/EBIT, and DDM converge on fair value ~1400-1700 GBp, meaning current price offers 0-15% margin of safety - INSUFFICIENT for even Tier A threshold.

**Catalyst:** H1 FY26 earnings 25-Feb could drive short-term volatility, but fundamentals support WAITING for 1300-1400 GBp for adequate MoS.

**Fair Value:** 1400-1650 GBp (Expected Value) | **Required Entry:** <=1300 GBp for 15%+ MoS

---

## 2. Business Understanding

### 2.1 Business Model

| Aspect | Description |
|--------|-------------|
| Problem solved | Premium alcoholic beverages for social occasions, celebration, status |
| Target customer | Global consumers across income levels, skewing premium/luxury |
| Revenue model | Consumables - repeat purchase, brand loyalty |
| % recurring | ~100% - spirits/beer are consumable, high repeat rate |

Diageo manufactures, markets, and distributes premium spirits (~75% revenue) and beer (~25%) globally across ~180 countries with 200+ brands. Key categories: Scotch whisky (Johnnie Walker), vodka (Smirnoff), gin (Tanqueray), tequila (Don Julio), rum (Captain Morgan), beer (Guinness).

### 2.2 Unit Economics

For B2C/B2B consumables, traditional CAC/LTV metrics don't apply directly. Instead:

| Metric | Value | Assessment |
|--------|-------|------------|
| Gross Margin | ~60% | Excellent - premium spirits have high margins |
| Brand investment/Revenue | ~15% | Heavy marketing spend to maintain brand equity |
| Operating Margin (adj) | 28.2% | Strong but declining (-68bp YoY) |
| FCF Conversion | ~50% of EBIT | Solid but leverage eats into available cash |
| Capex/Revenue | ~6% | Moderate - aging inventory requires capital |

**Key insight:** Spirits are "time-locked" - Scotch ages 10-18+ years, creating natural barriers but also working capital intensity.

### 2.3 Structure of Margins

| Margin | FY25 | 5y Avg | Trend | vs Peers |
|--------|------|--------|-------|----------|
| Gross | ~60% | ~60% | Stable | In-line (Pernod ~60%, Brown-Forman ~58%) |
| Operating (adj) | 28.2% | ~29% | Compressing | Slightly above peers |
| Net | ~10% (reported) | ~18% | DOWN (exceptionals) | Below due to one-offs |
| FCF | 13.6% ($2.7B/$20B) | ~13% | Stable | In-line |

**Margin trajectory:** Operating margins compressed 68bp in FY25 due to lower volumes, tariffs, and mix. Accelerate cost savings program ($625M over 3 years) should stabilize but not expand margins given revenue headwinds.

### 2.4 Why It's Cheap

**Market narrative:**
1. **Near-zero organic growth:** FY25 +1.7%, FY26 guided flat to slightly down
2. **China/US headwinds:** China white spirits (-7.5% APAC in Q1), US spirits -4.1%
3. **High leverage:** 3.4x EBITDA vs 2.5-3.0x target - limits buybacks, constrains dividend
4. **Payout ratio concern:** ~98% on reported earnings (63% on adjusted)
5. **Tariff exposure:** $200M annual impact from US tariffs

**My counter-thesis: THE MARKET IS MOSTLY RIGHT**

After rigorous multi-method valuation:
- DCF (3% growth, 8.5% WACC): Fair value ~1000-1550 GBp
- EV/EBIT (12x adjusted): Fair value ~1675 GBp
- DDM (2-3% growth, 8-9% Ke): Fair value ~1400-1800 GBp

**Convergence:** All methods point to fair value ~1400-1700 GBp. At 1690 GBp, there is NO margin of safety. The 5% yield is compensation for zero growth, not a bargain.

**My (limited) edge:** The market may be too pessimistic on medium-term recovery (2-3 years) if US/China normalize. But I cannot quantify this with confidence given guidance cuts.

### 2.5 Value Trap Checklist

| Factor | SI/NO | Comment |
|--------|-------|---------|
| Industry in secular decline | NO | Spirits growing 3-4% globally, but mature in developed markets |
| Imminent tech disruption | NO | Alcohol relatively immune |
| Management destroying value | NO | Adequate but not stellar - leverage buildup concerning |
| Balance deteriorating | **YES** | 3.4x leverage, above target, limited deleveraging visibility |
| Massive insider selling | NO | No unusual activity |
| Dividend cut recent/probable | **MAYBE** | Payout ~98% reported; sustainable on adjusted but risky if adjusted doesn't recover |
| Market share loss >2pp/3y | NO | Share stable, premiumization helping |
| ROIC < WACC last 3 years | NO | ROIC ~12-15% vs WACC ~8-9% |
| FCF negative >2 years | NO | Consistently positive |
| Goodwill >50% equity | **YES** | Significant intangibles from acquisitions |

**Total SI: 2-2.5** (borderline - NOT clear value trap, but leverage is key risk)

---

## 3. Key Financial Metrics

| Metric | Value | Sector Avg | Comment |
|--------|-------|-----------|---------|
| P/E Trailing | 21.9x | ~18x | Elevated on depressed earnings |
| P/E Forward | ~13x | ~15x | Looks cheap vs historical 27x avg |
| P/FCF | ~14x | ~15x | Reasonable |
| EV/EBITDA | ~11x | ~12x | Fair |
| EV/EBIT (adj) | 12.1x | 12-14x | Fair for sector |
| Dividend Yield | 4.9% | ~3% | High but risky |
| Payout Ratio (reported) | ~98% | ~50% | STRETCHED |
| Payout Ratio (adjusted) | ~63% | ~50% | Manageable if adjusted normalizes |
| Debt/Equity | ~2.7x | ~1.5x | HIGH |
| Net Debt/EBITDA | 3.4x | ~2.5x | HIGH - above target |
| Interest Coverage | ~6x | ~8x | Adequate but watch |
| ROE (current) | ~21% | ~18% | Declining from 34% |
| ROIC | ~12% | ~10% | Above WACC but declining |
| FCF Yield | ~7% | ~6% | Good but debt service priority |

---

## 4. Projections (Projection Framework)

### 4.1 Revenue Drivers

| Driver | Value | Source |
|--------|-------|--------|
| Global spirits TAM | ~$660B (2025) | Mordor Intelligence, Grand View |
| TAM growth | +3.5-4% CAGR | Industry consensus |
| Premium spirits TAM growth | +10% CAGR | Grand View Research |
| Diageo market share (global spirits) | ~8% | #1 globally |
| Market share trend | Stable | Maintaining but not gaining |
| Pricing power | **Moderate** | +0.8% price/mix FY25, but volume weakness |

**Revenue growth derivation:**
- TAM growth: +3.5%
- Market share change: 0% (stable)
- Pricing: +1.0% (can match inflation)
- **Implied organic revenue growth: ~4-5%**
- **REALITY CHECK: FY26 guidance is FLAT to slightly down due to China/US headwinds**

**My projection:** 0-2% revenue growth FY26-27, recovering to 3-4% FY28+ IF US/China normalize.

### 4.2 Margin Projections

| Year | Revenue Growth | Op. Margin (adj) | FCF ($B) |
|------|---------------|------------------|----------|
| FY25 (actual) | +1.7% | 28.2% | $2.7B |
| FY26E | 0% to -2% | 28-29% | $3.0B (guided) |
| FY27E | +2% | 28.5% | $3.0-3.2B |
| FY28E | +3% | 29% | $3.2-3.5B |

Cost savings from Accelerate ($625M over 3 years, 40% in FY26) should protect margins, but revenue headwinds offset expansion. Flat to slight improvement realistic.

### 4.3 WACC Derivation

```
Risk-free (UK 10Y gilt): 4.0%
Beta: 0.65 (defensive consumer staple)
ERP: 5.0%
Ke = 4.0% + 0.65 × 5.0% = 7.25%

Add-on for high leverage: +0.5%
Adjusted Ke = 7.75% (round to 8%)

Cost of debt (pre-tax): ~4.5% (interest/debt)
Tax rate: 23%
Kd after-tax = 4.5% × 0.77 = 3.5%

Capital structure:
Market cap: GBP 37.6B
Net debt: GBP 17.5B
EV: GBP 55.1B
E/V = 68%, D/V = 32%

WACC = (68% × 8%) + (32% × 3.5%) = 5.44% + 1.12% = 6.56%
```

**Sanity check:** 6.5% WACC seems LOW for a company with 3.4x leverage and declining growth. Using a more conservative 8-9% WACC for DCF is appropriate given execution risk.

---

## 5. Multi-Method Valuation

### 5.1 Method 1: DCF (Primary)

**Inputs:**
- Starting FCF: $2.7B (GBP 2.16B at 0.80 USD/GBP)
- Growth: 3% (conservative, below TAM due to current headwinds)
- WACC: 8.5% (conservative for wide-moat staple with high debt)
- Terminal growth: 2.0%
- Years: 5 + terminal
- Net debt: GBP 17.5B

**DCF Tool Results (with derived parameters):**
| Scenario | Growth | WACC | Fair Value (GBp) |
|----------|--------|------|------------------|
| Bear | 1% | 9.5% | 586 |
| Base | 3% | 8.5% | 991 |
| Bull | 5% | 7.5% | 1,566 |

**DCF verdict:** Even with optimistic 5% growth and 7.5% WACC, fair value ~1,566 GBp is BELOW current price of 1,690 GBp.

### 5.2 Method 2: EV/EBIT (Secondary)

**Inputs:**
- Adjusted EBIT FY25: $5.7B = GBP 4.56B
- Net debt: GBP 17.5B
- Shares: 2.22B

**Multiple selection:**
- Consumer staples typical: 12-16x
- Diageo adjustments: -1x for high leverage, -1x for zero growth
- Fair multiple range: 10-14x

| Scenario | Multiple | Fair EV | Fair Equity | Fair Price |
|----------|----------|---------|-------------|------------|
| Bear (10x) | 10x | GBP 45.6B | GBP 28.1B | 1,265 GBp |
| Base (12x) | 12x | GBP 54.8B | GBP 37.2B | 1,675 GBp |
| Bull (14x) | 14x | GBP 63.9B | GBP 46.4B | 2,086 GBp |

**EV/EBIT verdict:** Current price 1,690 GBp is essentially at BASE case fair value. No margin of safety.

### 5.3 Method 3: DDM (Tertiary - dividend aristocrat)

**Inputs:**
- Current dividend: 82.8 GBp (103.48 USD cents × 0.80 × 100)
- Yield: 4.9%
- Required return (Ke): 8-9%
- Sustainable dividend growth: 2-3% (given payout constraints)

**Gordon Growth Model:**
| Growth | Ke=8% | Ke=8.5% | Ke=9% |
|--------|-------|---------|-------|
| 2% | 1,407 GBp | 1,299 GBp | 1,206 GBp |
| 3% | 1,705 GBp | 1,550 GBp | 1,421 GBp |

**DDM verdict:** Fair value 1,300-1,700 GBp depending on assumptions. Current 1,690 GBp offers minimal MoS.

### 5.4 Valuation Reconciliation

| Method | Weight | Fair Value | Weighted |
|--------|--------|------------|----------|
| DCF Base | 40% | 991 GBp | 396 GBp |
| DCF Bull | 10% | 1,566 GBp | 157 GBp |
| EV/EBIT Base | 30% | 1,675 GBp | 503 GBp |
| DDM (3%, 8.5%) | 20% | 1,550 GBp | 310 GBp |
| **Expected Value** | **100%** | | **1,366 GBp** |

**Alternative (more generous) weighting:**
| Method | Weight | Fair Value | Weighted |
|--------|--------|------------|----------|
| DCF Base | 30% | 991 GBp | 297 GBp |
| EV/EBIT Base | 40% | 1,675 GBp | 670 GBp |
| DDM | 30% | 1,550 GBp | 465 GBp |
| **Expected Value** | **100%** | | **1,432 GBp** |

### 5.5 Margin of Safety Calculation

```
Expected Value (conservative): 1,366 GBp
Expected Value (generous): 1,432 GBp
Bear Case (DCF): 586 GBp
Bear Case (EV/EBIT): 1,265 GBp

Current price: 1,690 GBp

MoS vs Expected Value (conservative): -24% (OVERVALUED)
MoS vs Expected Value (generous): -18% (OVERVALUED)
MoS vs EV/EBIT Bear: -34% (OVERVALUED)
```

**CRITICAL FINDING:** Multi-method valuation shows Diageo is OVERVALUED at current price, not undervalued. The original thesis claiming 26% MoS was based on optimistic DCF parameters (5% growth, 9% WACC) that are not justified by current business trajectory.

---

## 6. Moat Assessment

| Aspect | Evaluation |
|--------|------------|
| Type | **Wide** |
| Sources | Brand intangibles (Johnnie Walker, Guinness, etc.), Scale advantage (1.5x nearest competitor), Regulatory barriers (licensing, age statements) |
| Quantitative evidence | ROIC ~12% vs WACC ~8% = positive spread; ROE 21% vs industry ~15% |
| Durability | 10+ years - brands appreciate with age |
| Threats | 1. Gen Z drinking less (structural, slow-moving), 2. Celebrity tequila brands taking share in fastest-growing category |

**Moat verdict:** Wide moat is intact. The problem is not the moat - it's the valuation. A wide moat doesn't guarantee a good investment at any price.

---

## 7. Risks

| Risk | Prob | Impact | Mitigant |
|------|------|--------|----------|
| Dividend cut if growth doesn't recover | Medium | High | Payout 63% on adjusted - sustainable IF earnings recover |
| Leverage remains elevated beyond FY28 | Medium | Medium | Accelerate program + asset sales; management committed |
| US/China weakness persists >3 years | Medium | High | Geographic diversification (Europe +3.5%, Africa +8.9%, LatAm +10.9%) |
| Gen Z secular decline in alcohol | Low | Medium | Very slow-moving; offset by emerging market growth |
| Tariff escalation (US) | High | Low | $200M impact manageable; pricing power can offset |
| Competition in tequila erodes Don Julio | Medium | Medium | Brand strength; premiumization protects margin |

**Kill Conditions (sell immediately):**
1. Dividend cut announced
2. Leverage exceeds 4.0x with no clear path to deleveraging
3. Organic growth negative for 3+ consecutive years
4. Management fraud or major governance scandal

---

## 8. Catalysts

| Catalyst | Timeframe | Prob | Impact |
|----------|-----------|------|--------|
| H1 FY26 earnings (25-Feb-2026) | 0-1m | N/A | HIGH volatility - sets tone for year |
| China/US recovery | 6-18m | Low-Med | +20-30% if growth returns to 3-4% |
| Accelerate savings exceed guidance | 12-24m | Medium | +10-15% margin expansion |
| Deleveraging ahead of schedule | 12-36m | Low-Med | Multiple re-rating |
| Tariff resolution | 6-12m | Low | +5-10% if tariffs removed |

**Near-term (H1 FY26 earnings 25-Feb):** Key metrics to watch:
1. Organic sales growth vs "flat to slightly down" guidance
2. Operating margin trajectory
3. Dividend maintained (expected yes)
4. Leverage path commentary

---

## 9. Macro Connection

| Macro Factor | Sensitivity | Current Status | Impact |
|--------------|-------------|----------------|--------|
| Interest rates | Low-Medium | Stable (Fed/BCE on hold) | Neutral - high debt but manageable rates |
| Recession risk | Medium | Low-Med probability | Spirits resilient but premium mix could suffer |
| USD strength | Medium | USD weakening slightly | Mixed - reports in USD, listed in GBP |
| Consumer confidence US | High | Weakening | NEGATIVE - US spirits -4.1% |
| China economy | High | Weak, stimulus ongoing | NEGATIVE - APAC -7.5% |

**Fit with World View:** CAUTIOUS

From world/current_view.md: Consumer staples are generally favorable, but Diageo has specific headwinds (China, US) that make it less defensive than pure utilities or pharma. The 5% yield provides some cushion but does not compensate for zero growth at current valuations.

---

## 10. Decision

| Field | Value |
|-------|-------|
| Recommendation | **WATCHLIST - DO NOT BUY at current price** |
| Tier | A (if bought at right price) |
| MoS required | >=15% (Tier A wide moat defensive) |
| MoS actual | **-15% to -24% (NEGATIVE - overvalued)** |
| Entry price target | **<=1,300 GBp** (provides ~15% MoS vs 1,520 FV) |
| Fair Value (weighted) | 1,400-1,520 GBp |
| Bull Target | 2,086 GBp (EV/EBIT 14x if growth resumes) |
| Sizing if bought | 3-4% (reduced due to leverage risk) |
| Horizon | 3-5 years |

### Standing Order Update

**PREVIOUS:** Buy at 1,700 GBp conditional on earnings
**NEW RECOMMENDATION:** **REMOVE STANDING ORDER**

At 1,700 GBp (or current 1,690 GBp), there is NO margin of safety based on multi-method valuation. The original thesis was too optimistic.

**New standing order:** BUY at **1,300 GBp or below** (post-earnings, after confirmation of dividend maintenance and leverage trajectory).

---

## 11. Autocritica (MANDATORY)

| Aspect | Response |
|--------|----------|
| Unvalidated assumptions | 1. Recovery to 3-4% growth in FY28+, 2. Leverage reaches 2.5-3.0x by FY28 |
| Possible biases | 1. Popularity bias (Diageo is well-known), 2. Anchoring to historical P/E premium |
| What would change my mind | 1. Q1/H1 shows organic growth inflection >3%, 2. Faster deleveraging, 3. Price drops to 1,300 GBp |
| My informational edge | **NONE** - this is a well-covered stock with 21+ analysts. Market is probably right. |
| What could be wrong | 1. I may be too conservative on growth recovery, 2. Premiumization tailwind could be stronger than I model |

### Critical Assessment of Original Thesis

The original thesis (pre-v2.0) claimed 26% MoS at 1,679 GBp. This was based on:
- DCF with 5% growth assumption (NOT justified by current trajectory)
- Single-method valuation (violated v2.0 rule of 2+ methods)
- No explicit business analysis framework
- No derivation of growth/WACC from fundamentals

**v2.0 correction:** Multi-method valuation shows fair value 1,400-1,520 GBp, meaning current price is OVERVALUED. This is a material change in recommendation.

---

## 12. Earnings Scenarios (25-Feb-2026)

### Scenario A: Beat + Positive Commentary (20% prob)
- Organic sales flat or slightly positive (beat "flat to down" guidance)
- Operating margin stable or improving
- Dividend maintained
- Management raises FY26 guidance
- **Expected price reaction:** +5-10% (1,800-1,900 GBp)
- **Action:** WAIT - still no MoS

### Scenario B: In-line (50% prob)
- Results match reduced guidance (flat to -2% organic)
- Margin stable, dividend maintained
- Leverage on track
- **Expected price reaction:** -2% to +2% (1,650-1,720 GBp)
- **Action:** WAIT - no MoS

### Scenario C: Miss + Negative Commentary (25% prob)
- Organic sales worse than guided
- Margin pressure
- Leverage concern raised
- **Expected price reaction:** -10-15% (1,450-1,550 GBp)
- **Action:** WATCH closely - approaching entry range

### Scenario D: Dividend Cut (5% prob)
- Earnings significantly worse
- Dividend reduced or suspended
- Management credibility damaged
- **Expected price reaction:** -20-30% (1,200-1,400 GBp)
- **Action:** REASSESS - thesis change, but potentially attractive entry if cut is conservative and temporary

---

## Peer Comparison

| Company | Fwd P/E | Yield | ND/EBITDA | Growth | Moat | Assessment |
|---------|---------|-------|-----------|--------|------|------------|
| Diageo (DGE.L) | ~13x | 4.9% | 3.4x | Flat | Wide | Overvalued at current price |
| Pernod Ricard (RI.PA) | ~12x | 6.3% | 3.0x | Low | Wide | **Better value** - lower leverage, higher yield |
| Brown-Forman (BF-B) | ~16x | 3.4% | 1.5x | Low | Wide | Premium for US focus, low debt |
| Remy Cointreau | ~25x | 3.0% | 2.5x | Low | Narrow | Overvalued |

**Relative value:** Pernod Ricard appears to offer better value with higher yield, lower leverage, and similar growth profile. If allocating to spirits sector, RI.PA may be preferable.

---

## Sources

- [Diageo FY25 Preliminary Results](https://www.diageo.com/en/news-and-media/press-releases/2025/2025-preliminary-results-year-ended-30-june-2025)
- [Diageo FY26 Q1 Trading Statement](https://www.diageo.com/en/news-and-media/press-releases/2025/diageo-issues-fiscal-26-q1-trading-statement)
- [Diageo Financial Calendar](https://www.diageo.com/en/investors/results-reports-and-events/financial-calendar)
- [Mordor Intelligence: Global Spirits Market](https://www.mordorintelligence.com/industry-reports/spirits-market)
- [Grand View Research: Premium Spirits Market](https://www.grandviewresearch.com/industry-analysis/premium-spirit-market)
- yfinance via price_checker.py, dcf_calculator.py
- Internal calculations for EV/EBIT and DDM

---

## Metadata

```yaml
ticker: DGE.L
fecha_creacion: 2026-02-02
ultima_revision: 2026-02-03 (v2.0 upgrade)
autor: fundamental-analyst
status: watchlist
next_review: 2026-02-26 (post H1 earnings)
price_target_entry: 1300 GBp
standing_order: REMOVED (was 1700 GBp)
```
